![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|4|1|97-104
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.4, Iss.1, 2004-02, pp. : 97-104
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design, Vol. 15, Iss. 7, 2009-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Estrogen Receptors as Therapeutic Targets in Breast Cancer
Current Topics in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Thrombin-Activated Receptors: Promising Targets for Cancer Therapy?
Current Medicinal Chemistry, Vol. 17, Iss. 2, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer
Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. :